ANI Pharmaceuticals Inc (ANIP)
Current ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 527,684 | 521,297 | 555,160 | 540,557 | 519,616 | 497,220 | 459,311 | 364,753 | 344,261 | 309,377 | 322,399 | 301,399 | 321,775 | 191,384 | 191,799 | 182,798 | 170,321 | 165,819 | 156,544 | 158,662 |
| Total current liabilities | US$ in thousands | 193,680 | 189,933 | 139,978 | 136,889 | 145,477 | 134,352 | 122,865 | 125,825 | 99,439 | 81,627 | 96,312 | 79,532 | 87,537 | 84,872 | 89,454 | 82,768 | 78,565 | 75,900 | 79,088 | 79,356 |
| Current ratio | 2.72 | 2.74 | 3.97 | 3.95 | 3.57 | 3.70 | 3.74 | 2.90 | 3.46 | 3.79 | 3.35 | 3.79 | 3.68 | 2.25 | 2.14 | 2.21 | 2.17 | 2.18 | 1.98 | 2.00 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $527,684K ÷ $193,680K
= 2.72
The current ratio of ANI Pharmaceuticals Inc has shown variations over the examined period. At the beginning of the observed period in March 2020, the current ratio was 2.00, indicating that the company had twice the current assets compared to its current liabilities. The ratio remained relatively stable around 2.00 to 2.21 from March 2020 to March 2021.
From December 2021 to June 2022, there was a significant increase in the current ratio, reaching its peak at 3.79 in December 2021. This signifies the company had a considerable increase in current assets relative to its current liabilities during this period.
However, from September 2022 to December 2024, the current ratio started to decline, indicating potential changes in the company's liquidity position. By December 2024, the current ratio had decreased to 2.72. This may imply that the company's current liabilities were starting to catch up to its current assets by the end of the examined period.
Overall, the current ratio of ANI Pharmaceuticals Inc has shown fluctuations, emphasizing the importance of monitoring changes in current assets and liabilities to assess the company's short-term liquidity and ability to meet its financial obligations.
Peer comparison
Dec 31, 2024